Missions

Le Pr Sébastien Gaujoux est spécialisé en chirurgie pancréatique, hépato-biliaire, oncologique et endocrinienne. Il exerce ses fonctions de Professeur des Universités à la Faculté de Santé Sorbonne Université et celles de praticien hospitalier à l’hôpital Pitié-Salpêtrière / Médecine Sorbonne Université.

Références

  1. Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study.
    Gaujoux S, Martin GL, Mirallié E, Regenet N, Le Bras M, Pattou F, Carnaille B, Cardot-Bauters C, Groussin L, Faron M, Chanson P, Najah H, Tabarin A, Sauvanet A, Ruszniewski P, Lifante JC, Walter T, Carrère N, Caron P, Deguelte S, Delemer B, Binquet C, Jannot AS, Goudet P.Br J Surg. 2022 Aug 16;109(9):872-879. doi: 10.1093/bjs/znac006.
  2. Reappraisal of a 2-Cm Cut-off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study
    Laura Maggino 1, Andrea Schmidt 2, André Käding 3, Sofia Westermark 4, Eugene P Ceppa 5, Massimo Falconi 6, Ammar A Javed 7, Luca Landoni 1, Ilaria Pergolini 8, Julie Perinel 9, Charles M Vollmer Jr 10, Malin Sund 4, Sebastien Gaujoux 11 12; on the behalf on the Pancreas 2000 research group. Annals of Surgery 273(5):p 973-981, May 2021. | DOI: 10.1097/SLA.0000000000003508
  3. Pancreatoduodenectomy Following Preoperative Biliary Drainage Using Endoscopic Ultrasound-Guided Choledochoduodenostomy Versus a Transpapillary Stent: A Multicenter Comparative Cohort Study of the ACHBT-FRENCH-SFED Intergroup
    Julien Janet 1, Jeremie Albouys 2 3 4, Bertrand Napoleon 5, Jeremie Jacques 2 3, Muriel Mathonnet 1, Julien Magne 6, Marie Fontaine 5, Charles de Ponthaud 7, Sylvaine Durand Fontanier 1 4, Sylvia S M Bardet 4, Raphael Bourdariat 8, Laurent Sulpice 9 10, Mickael Lesurtel 11, Romain Legros 2 3 4, Stephanie Truant 12, Fabien Robin 9 10, Frédéric Prat 13, Maxime Palazzo 14, Lilian Schwarz 15, Emmanuel Buc 16, Alain Sauvanet 11, Sebastien Gaujoux 7, Abdelkader Taibi 17 18 . Ann Surg Oncol . 2023 Apr 17.  doi: 10.1245/s10434-023-13466-8. Online ahead of print.
  4. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Gaujoux S, Torres J, Olson S, Winston C, Gonen M, Brennan MF, Klimstra DS, D’Angelica M, DeMatteo R, Fong Y, House M, Jarnagin W, Kurtz RC, Allen PJ.Ann Surg Oncol. 2012 Sep;19(9):2908-16. doi: 10.1245/s10434-012-2301-y. Epub 2012 Mar 13.PMID: 22411205
  5. Ischemic complications after pancreaticoduodenectomy: incidence, prevention, and management.
    Gaujoux S, Sauvanet A, Vullierme MP, Cortes A, Dokmak S, Sibert A, Vilgrain V, Belghiti J.Ann Surg. 2009 Jan;249(1):111-7. doi: 10.1097/SLA.0b013e3181930249.PMID: 19106685.